Home / Reports

Reports

US insurers switch up to 70% of drugs

A survey carried out by the Global Healthy Living Foundation (GHLF), a non-profit patient organisation, has shown that up to 70% of prescription medications are changed by health insurers, without doctors’ approval.

US drug shortages – frustration and safety concerns

According to a survey conducted by the non-profit ISMP, there is a high level of frustration and worries about safety, concerning recent drug shortages in the US.

Fewer generic applications in the EU in 2010

Figures published by the EMA in October 2010 on centralised procedures show a reduction in the number of generic applications filed and finalised this year up to September 2010. Although this number will undoubtedly increase by the end of the year, a marked difference is already evident in comparison to 2008 and 2009, when 30 and 38 generic applications, respectively, were filed compared to only 13 filed in 2010.

Are generic medicines too expensive in Europe?

Professor Steven Simoens speaks to GaBI Online about this and other issues surrounding generics.

Pharmacists could save the NHS GBP 1 billion

More than GBP 1 billion could be saved by the National Health Service (NHS) through better use of pharmacists in improving outcomes in public health and long-term conditions, a new report claims.

Savings from generic medicines use

The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Mr Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.

Recommendations to strengthen generic medicines markets

The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Ms Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.

Policies that advance the use of generic and biosimilar medicines

The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Ms Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.

Recommendations for developing generic medicines markets

The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Ms Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.

Strengths and weaknesses of developing generic medicines markets

The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Ms Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.

Generics News Research General

more

Biosimilars News Research General

more